Tumour microarrays (TMAs) were used to analyse the expression of UBE4B and FAT4 in the tumour and adjacent normal tissues of 94 patients with gastric cancer, as well as the corresponding clinicopathological information. This evidence concerns the gene UBE4B and gastric cancer.